We develop efficient, ultra-precise, and organic biological fungicides and bactericides

We develop efficient, ultra-precise and organic biological fungicides and bactericides

Why are we developing the next-gen of biological pesticides

>$220 billion

Crop diseases cause >$220 billion in annual losses

Global warming

perpetuates crop disease outbreaks, some of which destroy >50% of staple crops

Toxic and ineffective

Antimicrobial pesticides are often ineffective and toxic for humans and the environment

> 90% of Americans

have dangerous pesticides in their bodies

We develop safe and effective in different environments bactericides and fungicides

We use targeted approaches, including bacteriophages - safe bacterial viruses

#1 Research Pipeline

Saving the US citrus industry

NOW

Huanglongbing, also known as citrus greening, is a devastating and incurable disease of citruses that is destroying the US citrus industry

>3.2

citrus price increase

>40%

decrease in orange production

in 10-15

years, the industry is likely to disappear

Our solution

We’re developing a safe, precise, and organic bacteriophage-based solution to cure citrus greening

#2 Pipeline

Platform technology to control fungal diseases in different environments

NOW

Fungal pathogens devastate agriculture

>80%

of crop diseases are caused by fungal organisms

Toxicity

Existing fungicides are often ineffective and can be toxic for humans and the environment

Advantages:

Uniphage’s fungicides are made to work in different environments

Our products have a significantly higher chance of in-field success. Long-term, this leads to more cost-efficient development and production of new solutions.

We're developing cutting-edge AI algorithms to enable our solutions to be more efficient

Our solution

Our technology will allow to faster develop bacteriophage-based solutions that will work in real-life settings even against rare bacterial pathogens

1 stage of technology development

Predict phage-host interactions

Advantages:

Quickly and precisely finding characterized phages that will work in-field, thus significantly reducing the chance of unsuccessful and expensive field trials

Using the same or very similar phages for a range of diseases, reducing regulatory hurdles

Little additional characterization is necessary

2 stage of technology development

Modify phage-host interactions

Advantages:

Precise change of desired phage characteristics to increase phage effectiveness and change hosts

Team

Sofia Sigal-Passeck

founder and CEO | Biz Dev and Science

Sofia is a Yale-NUS alumna and a PI on an NSF SBIR grant. She is excited to use microbiology to build a safer and more sustainable world!

Sophia Xu

Research

Sophia Xu is a recent graduate from the University of Texas at Austin. She has been involved in synthetic biology and phage research for 3+ years through leading the UT Austin iGEM Team and independent research grants. She is excited to expand her experience at Uniphage to create a more environmentally sustainable future!

Brendan Jamieson

COmputational Biologist <- Summer intern 2022

Brendan is a graduate student studying epidemiology and bioinformatics at Virginia Commonwealth University. He is excited to use his background in bioinformatics and his new found knowledge in epidemiology to create a safer and healthier environment for all living things across the globe.

Betty Wang

Intern SUmmer'22 - Business Development and Social Media

Betty is a third-year student at Yale-NUS College with a major in Economics and a minor in Environmental Studies. She hopes to use her skills in building a more environmentally sustainable future.